ALA Diagnostics, S.L.
Revolutionizing Multiple Sclerosis diagnosis
Status
IP Type
Patent
Time
15 years
Countries
Coverage
The use of our biomarker in Multiple Sclerosis
New patent submitted in December 2021. Combination of biomarkers
Know more of this patent
This information is confidential, do not share or copy.
You can visit their website or
Under evaluation at least till: July 28th, 2022
KEEP REVIEWING